At least 40 countries, representing more than half of the world’s population, have expressed interest in Russia’s coronavirus vaccine, the team behind it have said as mass vaccination begins in Moscow.
At a presentation to the United Nations on Thursday, scientists from the Gamaleya Institute, which developed the formula, said that preliminary orders have been placed for more than 1.2 billion doses. Trials involving 45,000 people across the globe have concluded that 95 percent of those given both doses of Sputnik V develop immunity to the virus.
Continue reading https://on.rt.com/awf9